Alexander Y Walley

Alexander Y Walley

Professor of Medicine, Boston University School of Medicine
在 bu.edu 的电子邮件经过验证
被引用次数：10602
overdose HIV naloxone buprenorphine
David R Brown

David R Brown

University of Minnesota
在 umn.edu 的电子邮件经过验证
被引用次数：6539
pharmacology opioid intestine naloxone
Andrew McAuley

Andrew McAuley

Glasgow Caledonian University
在 phs.scot 的电子邮件经过验证
被引用次数：3017
PWID naloxone BBV HCV HIV
Rachel Winograd

Rachel Winograd

University of Missouri, St. Louis
在 mimh.edu 的电子邮件经过验证
被引用次数：624
opioid use disorder naloxone harm reduction treatment
Chin Hwa (Gina) Dahlem

Chin Hwa (Gina) Dahlem

University of Michigan School of Nursing
在 umich.edu 的电子邮件经过验证
被引用次数：585
Substance use overdose prevention naloxone
Fiona O'Sullivan

Fiona O'Sullivan

Broadstreet HEOR, Vancouver
在 tcd.ie 的电子邮件经过验证
被引用次数：542
Vitamin D Naloxone Substance Use Frequent Users of Emergency Departments Migraine
Brett Wolfson-Stofko, PhD

Brett Wolfson-Stofko, PhD

Center for Drug Use and HIV/HCV Research (CDUHR) - New York University
在 ndri.org 的电子邮件经过验证
被引用次数：305
Supervised Injection Facilities Overdose Naloxone Public Injection HCV
Arne Kristian Skulberg

Arne Kristian Skulberg

Oslo University Hospital
在 ntnu.no 的电子邮件经过验证
被引用次数：219
Opioid overdose naloxone emergency medicine clinical trials
Farah Riazi

Farah Riazi

在 mountsinai.org 的电子邮件经过验证
被引用次数：61
hepatitis C substance use naloxone people who use drugs
Erin G. Major

Erin G. Major

Health Services Research PhD student, Boston University
在 bu.edu 的电子邮件经过验证
被引用次数：40
harm reduction substance use disorders perinatal substance exposure buprenorphine naloxone
1 - 10